Variant report
Variant | esv3397341 |
---|---|
Chromosome Location | chr6:118223059-118225507 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:2)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:2 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | POLR2A | chr6:118225281-118225514 | MCF10A-Er-Src | breast: | n/a | n/a |
2 | POLR2A | chr6:118223084-118223255 | MCF10A-Er-Src | breast: | n/a | n/a |
No data |
No data |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
SLC35F1 | TF binding region |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs543489365 | chr6:118223409-118223410 | Bivalent Enhancer Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs192146352 | chr6:118223449-118223450 | Bivalent Enhancer Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs565564474 | chr6:118223466-118223467 | Bivalent Enhancer Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs183688266 | chr6:118223467-118223468 | Bivalent Enhancer Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs547985424 | chr6:118223477-118223478 | Bivalent Enhancer Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs188407751 | chr6:118223506-118223507 | Bivalent Enhancer Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs530165507 | chr6:118223520-118223521 | Bivalent Enhancer Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs577406901 | chr6:118223600-118223601 | Bivalent Enhancer Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs181300643 | chr6:118223621-118223622 | Bivalent Enhancer Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs537027577 | chr6:118223673-118223674 | Bivalent Enhancer Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs12525619 | chr6:118223698-118223699 | Bivalent Enhancer Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs117498984 | chr6:118223734-118223735 | Bivalent Enhancer Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs190162787 | chr6:118223788-118223789 | Bivalent Enhancer Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs374662745 | chr6:118223818-118223819 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs373601294 | chr6:118223826-118223827 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs182348923 | chr6:118223837-118223838 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs370595629 | chr6:118223840-118223841 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs535584342 | chr6:118223847-118223848 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs560350662 | chr6:118223866-118223867 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs116625999 | chr6:118223884-118223885 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs527602420 | chr6:118223963-118223964 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs60194924 | chr6:118224057-118224058 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs187025643 | chr6:118224077-118224078 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs11440966 | chr6:118224197-118224198 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs3950979 | chr6:118224224-118224225 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs577569472 | chr6:118224241-118224242 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs368640287 | chr6:118224242-118224243 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs62432034 | chr6:118224259-118224260 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs199519312 | chr6:118224317-118224318 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs559934843 | chr6:118224327-118224328 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs376750166 | chr6:118224347-118224348 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs368536470 | chr6:118224426-118224427 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs369071602 | chr6:118224448-118224449 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs111994848 | chr6:118224449-118224450 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs549890183 | chr6:118224457-118224458 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs530226040 | chr6:118224472-118224473 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs376831892 | chr6:118224475-118224476 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs7745854 | chr6:118224476-118224477 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
39 | rs552124646 | chr6:118224478-118224479 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs570417432 | chr6:118224555-118224556 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs192313507 | chr6:118224623-118224624 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs546486545 | chr6:118224640-118224641 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs532704596 | chr6:118224677-118224678 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs568274908 | chr6:118224716-118224717 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs180773880 | chr6:118224744-118224745 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs557036875 | chr6:118224780-118224781 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs575223847 | chr6:118224914-118224915 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs539447083 | chr6:118224965-118224966 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs547682440 | chr6:118224973-118224974 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs557748721 | chr6:118224983-118224984 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Uveal melanoma | 21693616 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Biliary cancer | 19435499 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Malaria | 21533027 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Autism | 21448237 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Autism | 22495311 | CNVD |
Gastric cancer | 17908304 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 19010834 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Breast cancer | 16608533 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Prostate cancer | 16705090 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Ependymoma | 16718352 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Intracranial tumor | 16823260 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 16272173 | CNVD |
Prostate cancer | 18632612 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Wilms tumour | 21544195 | CNVD |
Prostate cancer | 19242612 | CNVD |
Glioma | 21046410 | CNVD |
Primary central nervous system lymphoma | 21088137 | CNVD |
Zellweger syndrome | 21572526 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Malignant melanoma | 18718029 | CNVD |
Lung adenocarcinoma | 21935476 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 21858162 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Breast cancer | 17603634 | CNVD |
Chondromyxoid Fibroma | 20696777 | CNVD |
Cancer | 21183584 | CNVD |
Developmental delay | 19490664 | CNVD |
Non-muscle invasive bladder neoplasm | 19445696 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Prostate cancer | 16573809 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Breast cancer | 21785460 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Prostate cancer | 16461572 | CNVD |
Neurocytoma | 17123091 | CNVD |
Cancer | 20164920 | CNVD |
Breast cancer | 21364760 | CNVD |
Chordoma | 21602918 | CNVD |
Kartagener syndrome | 16639409 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Breast cancer | 17133270 | CNVD |
Follicular lymphoma | 18703704 | CNVD |
Mental retardation | 17621639 | CNVD |
Hypoplastic | 20877625 | CNVD |
Hypotonia | 20877625 | CNVD |
Mental retardation | 20877625 | CNVD |
Microcephaly | 20877625 | CNVD |
brachycephaly | 20877625 | CNVD |
epicanthic folds | 20877625 | CNVD |
micrognathia | 20877625 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Metastatic melanoma | 18483359 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr6:118223400-118223800 | Bivalent Enhancer | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
2 | chr6:118223400-118223800 | Enhancers | Ganglion Eminence derived primary cultured neurospheres | brain |
3 | chr6:118223800-118226600 | Weak transcription | Ganglion Eminence derived primary cultured neurospheres | brain |